Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | SCN1A | P35498 | 4/20 | 0.45 |
| ▸ | SCN2A | Q99250 | 4/20 | 0.45 |
| ▸ | SCN3A | Q9NY46 | 4/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | MMP9 | P14780 | 2/20 | 0.41 |
| ▸ | MMP12 | P39900 | 2/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | FABP7 | O15540 | 1/20 | 0.40 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24361197 | 0.84 | SCN8A (0.38) | KMT2AMEN1NPC1RAB9AMMP9 | |
| SCHEMBL5987325 | 0.79 | MEN1 (0.53) | KMT2AMEN1SCN1ASCN2ASCN3A | |
| SCHEMBL29302 | 0.79 | MEN1 (0.57) | KMT2AMEN1SCN1ASCN2ASCN3A | |
| SCHEMBL10707097 | 0.79 | MEN1 (0.57) | KMT2AMEN1SCN1ASCN2ASCN3A | |
| SCHEMBL31069910 | 0.79 | MEN1 (0.57) | KMT2AMEN1SCN1ASCN2ASCN3A | |
| SCHEMBL8607117 | 0.79 | MEN1 (0.57) | KMT2AMEN1SCN1ASCN2ASCN3A | |
| SCHEMBL19668120 | 0.79 | MEN1 (0.57) | KMT2AMEN1SCN1ASCN2ASCN3A | |
| SCHEMBL29372521 | 0.79 | MEN1 (0.57) | KMT2AMEN1SCN1ASCN2ASCN3A | |
| SCHEMBL8423858 | 0.78 | MEN1 (0.52) | KMT2AMEN1SCN1ASCN2ASCN3A | |
| Ammonia Solution, Strong SCHEMBL27808056 | 0.78 | MEN1 (0.52) | KMT2AMEN1SCN1ASCN2ASCN3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220127225-A1 | ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127225-A1 | ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | CACNA1F, SLC6A5, IDUA | KMT2A 2537/4885MEN1 2769/4885SCN1A 967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.